Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09MTV
|
|||
| Former ID |
DNC007407
|
|||
| Drug Name |
4-(dimethylamino)-N-(thiazol-2-yl)benzamide
|
|||
| Synonyms |
4-(dimethylamino)-N-(1,3-thiazol-2-yl)benzamide; AC1M7A6S; CHEMBL425124; MolPort-004-070-500; ZINC3346941; AKOS017059191; MCULE-5265697892; N-(Thiazole-2-yl)-4-(dimethylamino)benzamide; Z28173761
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H13N3OS
|
|||
| Canonical SMILES |
CN(C)C1=CC=C(C=C1)C(=O)NC2=NC=CS2
|
|||
| InChI |
1S/C12H13N3OS/c1-15(2)10-5-3-9(4-6-10)11(16)14-12-13-7-8-17-12/h3-8H,1-2H3,(H,13,14,16)
|
|||
| InChIKey |
RGXFQNTVZRGDNG-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | LOX-5 messenger RNA (ALOX5 mRNA) | Target Info | Inhibitor | [1] |
| BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
| Resolvin D biosynthesis | ||||
| Leukotriene biosynthesis | ||||
| Lipoxin biosynthesis | ||||
| Aspirin triggered resolvin D biosynthesis | ||||
| Aspirin triggered resolvin E biosynthesis | ||||
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Serotonergic synapse | ||||
| Ovarian steroidogenesis | ||||
| Toxoplasmosis | ||||
| NetPath Pathway | IL4 Signaling Pathway | |||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Arachidonic acid metabolism | |||
| Eicosanoid Synthesis | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem. 2007 May 31;50(11):2640-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.